IPF (Idiopathic Pulmonary Fibrosis) is a condition in which the lung tissue becomes thickened and scarred over time, which can lead to breathing difficulties and reduced lung function. While IPF primarily affects the lungs, it can also have an impact on other organs in the body, including the heart.
Studies have suggested that IPF may increase the risk of heart failure. This may be due to several factors, including reduced oxygen supply to the heart, inflammation in the lungs and other parts of the body, and the development of pulmonary hypertension (high blood pressure in the lungs).
In addition, some medications used to treat IPF, such as pirfenidone and nintedanib, may also have an impact on the heart. These medications can cause gastrointestinal side effects, which can lead to weight loss and malnutrition, both of which can increase the risk of heart failure.
It’s important for individuals with IPF to be aware of the potential risk of heart failure and to discuss any concerns with their healthcare provider. Regular monitoring of heart function may also be recommended for individuals with IPF, particularly if they are taking medications that can impact heart health.
